A revolution in understanding of brain function is occurring across genetic, molecular, and circuit levels in humans and models of mental illness. This profound development, owing to its very success, has resulted in a complex scientific landscape, and unwittingly diluted the field with multiple potentially relevant molecular pathways and candidate biomarkers of brain circuit dysfunction. This complexity leads to challenges in deciding upon best practices to endorse within pharmaceutical drug development programs in Neuroscience.
The Roche Pharma Research and Early Development (pRED) Neuroscience disease translational area (DTA) unit organized a one-day symposium entitled "Genes, Circuits, Behavior: Developing New Translational Approaches for Mental Health". The goal of the symposium was to bring together leading basic, clinical, and translational investigators and members of the Roche Neuroscience DTA to discuss optimal approaches to drug development for mental disorders.
We are pleased to provide a summary report covering the topics presented and discussed at the event, alongside a selection of videos where attending external experts and members of the Roche Neuroscience DTA provide their opinion on the event and associated themes.
Impressions from the Neuroscience Symposium
Participants at the Neuroscience Symposium provide their thoughts on the event, the thought provoking content on offer and what learnings they have taken away to advance future research in psychiatry.more
Current challenges in psychiatry
Leading experts and members of the Roche Neuroscience DTA take inspiration from the Neuroscience Symposium to discuss the current challenges in psychiatry and how these may be overcome.more
Optimism in autism research
Participants at the Neuroscience Symposium provide their perspective on our understanding of the science in autism and why they are optimistic regarding the advent of new treatments for the disease in the future.more
Genetics in psychiatry
Participants at the Neuroscience Symposium shed light on how genetics are influencing our understanding of psychiatry and what this means for diseases such as schizophrenia.more